These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2563532)

  • 21. [Chronic interstitial nephritis after treatment with 5-aminosalicylic acid].
    Henning HV; Meinhold J; Eisenhauer T; Scheler F; Gröne HJ
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1091. PubMed ID: 2737099
    [No Abstract]   [Full Text] [Related]  

  • 22. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.
    D'Arienzo A; Panarese A; D'Armiento FP; Lancia C; Quattrone P; Giannattasio F; Boscaino A; Mazzacca G
    Am J Gastroenterol; 1990 Sep; 85(9):1079-82. PubMed ID: 2202199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrotic syndrome after treatment with 5-aminosalicylic acid.
    Novis BH; Korzets Z; Chen P; Bernheim J
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1442. PubMed ID: 3132281
    [No Abstract]   [Full Text] [Related]  

  • 24. [5-aminosalicylic acid-associated pancreatitis].
    Tromm A; May B
    Dtsch Med Wochenschr; 1991 Jul; 116(28-29):1125. PubMed ID: 2065601
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute interstitial nephritis due to 5-aminosalicylic acid.
    Mehta RP
    CMAJ; 1990 Nov; 143(10):1031-2. PubMed ID: 2224669
    [No Abstract]   [Full Text] [Related]  

  • 26. Minimal-change nephropathy induced by 5-aminosalicylic acid.
    Zorzets Z; Bernheim J
    Nephrol Dial Transplant; 1996 Jun; 11(6):1187-8. PubMed ID: 8966008
    [No Abstract]   [Full Text] [Related]  

  • 27. Mesalazine induced exacerbation of ulcerative colitis.
    Kapur KC; Williams GT; Allison MC
    Gut; 1995 Dec; 37(6):838-9. PubMed ID: 8537058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.
    Campieri M; De Franchis R; Bianchi Porro G; Ranzi T; Brunetti G; Barbara L
    Scand J Gastroenterol; 1990 Jul; 25(7):663-8. PubMed ID: 2204103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute interstitial nephritis caused by 5-aminosalicylic acid?].
    Ruf-Ballauf W; Hofstädter F; Krentz K
    Internist (Berl); 1989 Apr; 30(4):262-4. PubMed ID: 2661466
    [No Abstract]   [Full Text] [Related]  

  • 30. [Side effects of 5-aminosalicylic acid].
    Marteau P; Cellier C
    Gastroenterol Clin Biol; 1997; 21(5):377-86. PubMed ID: 9208013
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nephritis from 5-aminosalicylic acid].
    von Mühlendahl KE
    Dtsch Med Wochenschr; 1989 Feb; 114(6):236. PubMed ID: 2917484
    [No Abstract]   [Full Text] [Related]  

  • 32. Lung and skin hypersensitivity to 5-aminosalicylic acid.
    le Gros V; Saveuse H; Lesur G; Brion N
    BMJ; 1991 Apr; 302(6782):970. PubMed ID: 1827746
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of mesalamine and olsalazine in ulcerative colitis.
    Gait JE; Powell JH; Regalli G
    Am Fam Physician; 1993 Nov; 48(7):1234, 1236. PubMed ID: 8237737
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
    van Hees PA; Bakker JH; van Tongeren JH
    Gut; 1980 Jul; 21(7):632-5. PubMed ID: 6107263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatitis induced by mesalamine.
    Erdkamp F; Houben M; Ackerman E; Breed W; van Spreeuwel J
    Neth J Med; 1992 Aug; 41(1-2):71-3. PubMed ID: 1407243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncoated versus coated 5-aminosalicylic acid in Crohn's disease.
    Bossi A; Giuliani GE; Del Poggio P; Fenili D; Ragaini S
    Lancet; 1989 Feb; 1(8632):276. PubMed ID: 2563434
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of diarrhea related to iron content of infant formula: lack of evidence to support the use of low-iron formula as a supplement for breastfed infants.
    Scariati PD; Grummer-Strawn LM; Fein SB; Yip R
    Pediatrics; 1997 Mar; 99(3):E2. PubMed ID: 9099767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesalazine toxicity.
    Honeybourne D
    BMJ; 1994 Feb; 308(6927):533-4. PubMed ID: 8166873
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed onset of weanling diarrhoea associated with high breast milk intake.
    Watkinson M
    Trans R Soc Trop Med Hyg; 1981; 75(3):432-5. PubMed ID: 7324111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.